Louis Fehrenbacher Selected Research

Louis Fehrenbacher Research Topics

Disease

49	Breast Neoplasms (Breast Cancer) 10/2022 - 02/2002
27	Neoplasms (Cancer) 10/2022 - 06/2005
8	Disease Progression 12/2018 - 01/2003
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 06/2004
7	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 01/2003
6	Hypertension (High Blood Pressure) 12/2017 - 06/2004
5	Amenorrhea 02/2022 - 06/2010
5	Fatigue 02/2020 - 07/2013
5	Colonic Neoplasms (Colon Cancer) 04/2014 - 06/2007
4	Neutropenia 02/2020 - 01/2012
4	Peripheral Nervous System Diseases (PNS Diseases) 01/2018 - 07/2013
4	Hemorrhage 09/2012 - 05/2005
3	Anemia 02/2020 - 01/2018
3	Diarrhea 11/2013 - 05/2008
2	Nausea 02/2020 - 01/2020
2	Alopecia (Baldness) 02/2020 - 12/2012
2	Arthralgia (Joint Pain) 01/2019 - 01/2018
2	Left Ventricular Dysfunction 01/2019 - 01/2012
2	Pain (Aches) 01/2018 - 01/2017
2	Cardiotoxicity 12/2017 - 11/2005
2	Heart Diseases (Heart Disease) 12/2017 - 02/2002
2	Noninfiltrating Intraductal Carcinoma (DCIS) 02/2016 - 02/2016
2	Margins of Excision 02/2016 - 02/2016
2	Hand-Foot Syndrome 09/2015 - 01/2012
2	Exanthema (Rash) 11/2013 - 05/2008
2	Heart Failure 11/2013 - 10/2005
2	Body Weight (Weight, Body) 01/2012 - 06/2004
2	Prostatic Neoplasms (Prostate Cancer) 12/2007 - 02/2007
2	Osteoporosis 06/2006 - 03/2006
1	Brain Neoplasms (Brain Tumor) 01/2021
1	Triple Negative Breast Neoplasms 02/2020
1	Vomiting 01/2020
1	Urinary Tract Infections (Urinary Tract Infection) 01/2019
1	Back Pain (Backache) 01/2019
1	Obesity 01/2018
1	Chronic Pain 01/2018
1	Hyperlipidemias (Hyperlipidemia) 12/2017
1	Carcinoid Tumor (Carcinoid) 11/2016
1	Neuroendocrine Carcinoma 11/2016
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2016
1	Thrombosis (Thrombus) 02/2016

Drug/Important Bio-Agent (IBA)

18	Bevacizumab (Avastin)FDA Link 07/2017 - 01/2003
15	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2022 - 06/2005
14	Trastuzumab (Herceptin)FDA Link 10/2022 - 02/2002
14	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2022 - 06/2005
12	Hormones (Hormone)IBA 10/2022 - 04/2008
12	Tamoxifen FDA LinkGeneric 01/2019 - 06/2005
12	Docetaxel (Taxotere)FDA Link 12/2018 - 02/2007
10	ErbB Receptors (EGF Receptor)IBA 10/2022 - 11/2005
10	AnthracyclinesIBA 10/2022 - 02/2005
10	Fluorouracil (Carac)FDA LinkGeneric 02/2022 - 01/2003
9	taxaneIBA 10/2022 - 02/2005
9	Paclitaxel (Taxol)FDA LinkGeneric 12/2017 - 06/2004
8	B 31IBA 01/2019 - 10/2005
8	Leucovorin (Folinic Acid)FDA Link 04/2014 - 01/2003
7	Capecitabine (Xeloda)FDA Link 01/2021 - 02/2005
7	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2016 - 06/2007
6	human ERBB2 proteinIBA 10/2022 - 11/2005
6	Monoclonal AntibodiesIBA 10/2007 - 01/2003
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2007 - 01/2003
5	Gemcitabine FDA Link 02/2020 - 01/2012
4	Taxoids (Taxanes)IBA 10/2022 - 06/2010
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2014
4	atezolizumabIBA 12/2018 - 04/2016
3	talazoparibIBA 02/2020 - 01/2018
3	Aromatase InhibitorsIBA 01/2019 - 01/2012
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2014 - 10/2007
3	Estrogen ReceptorsIBA 06/2010 - 06/2005
3	Raloxifene Hydrochloride (Evista)FDA Link 06/2010 - 03/2006
3	Irinotecan (Camptosar)FDA LinkGeneric 05/2008 - 06/2004
2	Epirubicin (Ellence)FDA LinkGeneric 02/2022 - 02/2010
2	Clodronic Acid (Clodronate)IBA 01/2021 - 07/2012
2	Vinorelbine (Navelbine)FDA LinkGeneric 02/2020 - 01/2018
2	Poly Adenosine Diphosphate RiboseIBA 02/2020 - 01/2018
2	eribulin FDA Link 02/2020 - 01/2018
2	Anastrozole (Arimidex)FDA LinkGeneric 02/2016 - 02/2016
2	P-2 (P 2)IBA 06/2010 - 06/2006
2	AndrogensIBA 12/2007 - 02/2007
1	pertuzumabIBA 10/2022
1	Ado-Trastuzumab EmtansineIBA 10/2022
1	Zoledronic Acid (Zometa)FDA Link 01/2021
1	tucatinibIBA 01/2021
1	Anti-Mullerian HormoneIBA 01/2021
1	beta-Aminoethyl Isothiourea (AET)IBA 02/2020
1	Letrozole (Femara)FDA LinkGeneric 01/2019
1	Biological ProductsIBA 11/2018
1	LigandsIBA 01/2018
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 01/2018
1	B7-H1 AntigenIBA 04/2016

Therapy/Procedure

26	Drug Therapy (Chemotherapy) 06/2022 - 01/2003
26	Therapeutics 02/2022 - 01/2003
10	Adjuvant Chemotherapy 10/2020 - 06/2005
5	Neoadjuvant Therapy 07/2017 - 02/2010
3	Segmental Mastectomy (Lumpectomy) 06/2022 - 02/2016
3	Radiotherapy 02/2016 - 01/2011
2	Combination Drug Therapy (Combination Chemotherapy) 09/2013 - 06/2004
1	Simple Mastectomy 06/2022
1	Immunotherapy 12/2018
1	Mastectomy (Mammectomy) 01/2018
1	Activities of Daily Living (ADL) 01/2017